These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 5595387)

  • 21. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 2nd communication: distribution to organs and tissues in male, female and pregnant rats, and characteristics of protein binding in plasma.
    Steinke W; Ahr HJ; Hirayama M
    Arzneimittelforschung; 1997 Aug; 47(8):939-48. PubMed ID: 9296280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacokinetics of sulfamethopyrazine in man. 1st experiences with minimum dosages].
    Boschi F; Clini V; Gialdroni-Grassi G
    G Ital Chemioter; 1965; 12(1):67-73. PubMed ID: 5881987
    [No Abstract]   [Full Text] [Related]  

  • 23. [Studies on the serum protein binding and renal elimination of isomeric sulfonamides (5-sulfanilamide-3-ethyl-1,2,4-thiodiazol and 5-sulfanilamido-2-ethyl-1,3,4-thiodiazol)].
    Irmscher K; Gabe D; Jahnke K; Scholtan W
    Arzneimittelforschung; 1966 Aug; 16(8):1019-25. PubMed ID: 6014883
    [No Abstract]   [Full Text] [Related]  

  • 24. [Quantitative changes in glucocorticoid binding capacity of blood plasma, liver and small intestine mucosa following consumption of various dietary proteins].
    Tegeler G; Schülke B
    Acta Biol Med Ger; 1980; 39(4):445-54. PubMed ID: 7445894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding of chlorpheniramine enantiomers to human plasma proteins.
    Hiep BT; Gimenez F; Khanh VU; Hung NK; Thuillier A; Farinotti R; Fernandez C
    Chirality; 1999; 11(5-6):501-4. PubMed ID: 10368923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stereoselective binding of zopiclone to human plasma proteins.
    Fernandez C; Gimenez F; Thuillier A; Farinotti R
    Chirality; 1999; 11(2):129-32. PubMed ID: 9951403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors affecting the plasma protein binding of verapamil and norverapamil in man.
    Yong CL; Kunka RL; Bates TR
    Res Commun Chem Pathol Pharmacol; 1980 Nov; 30(2):329-39. PubMed ID: 7444161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo and in vitro studies on the binding of salicylate to human plasma proteins: evidence for one type of binding site.
    Cham BE; Bochner F; Imhoff DM; Byrne G; Gunsberg M
    J Pharmacol Exp Ther; 1982 Mar; 220(3):648-53. PubMed ID: 7062274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of selected drugs on the in vitro protein binding of repaglinide in human plasma.
    Plum A; Müller LK; Jansen JA
    Methods Find Exp Clin Pharmacol; 2000 Apr; 22(3):139-43. PubMed ID: 10893694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma-protein binding of tricyclic antidepressants.
    Braithwaite RA
    Postgrad Med J; 1980; 56 Suppl 1():107-11. PubMed ID: 6994085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of plasma protein binding on in vivo activity and brain penetration of glycine/NMDA receptor antagonists.
    Rowley M; Kulagowski JJ; Watt AP; Rathbone D; Stevenson GI; Carling RW; Baker R; Marshall GR; Kemp JA; Foster AC; Grimwood S; Hargreaves R; Hurley C; Saywell KL; Tricklebank MD; Leeson PD
    J Med Chem; 1997 Dec; 40(25):4053-68. PubMed ID: 9406596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms for the formation of protein-bound homocysteine in human plasma.
    Togawa T; Sengupta S; Chen H; Robinson K; Nonevski I; Majors AK; Jacobsen DW
    Biochem Biophys Res Commun; 2000 Nov; 277(3):668-74. PubMed ID: 11062011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The binding of 2-sul-fanilamido-5-methoxypyrimidine on protein and its level in the serum, tissue, cerebrospinal fluid and bile].
    WOEHLER F; OTTE W; JUNG H
    Arzneimittelforschung; 1961 Aug; 11():736-9. PubMed ID: 14007826
    [No Abstract]   [Full Text] [Related]  

  • 34. [Physicochemical studies on the suspension syrup. 3. The electrokinetic potential of some sulfamines].
    Nakagaki M; Kawamura S
    Yakugaku Zasshi; 1965 Oct; 85(10):894-8. PubMed ID: 5893594
    [No Abstract]   [Full Text] [Related]  

  • 35. [Meaning of binding sulfamines to plasma proteins].
    Berlin H
    Rev Bras Gastroenterol; 1967; 19(4):19-23. PubMed ID: 5595387
    [No Abstract]   [Full Text] [Related]  

  • 36. A method of determining in man protein-binding and antimicrobial activity of long-acting sulfonamides.
    Tauber LF; Batterman RC; Bell ME
    Proc West Pharmacol Soc; 1965; 8():67. PubMed ID: 5863054
    [No Abstract]   [Full Text] [Related]  

  • 37. [Binding of sulfonamides to protein. 6. Determination of protein binding of sulfonamides by means of ultracentrifuge and gel filtration].
    Scholtan W
    Arzneimittelforschung; 1965 Dec; 15(12):1433-41. PubMed ID: 5899818
    [No Abstract]   [Full Text] [Related]  

  • 38. Disposition of L-738,167, a potent and long-acting fibrinogen receptor antagonist, in dogs. Dose-dependent pharmacokinetics.
    Prueksaritanont T; Gorham LM; Naue JA; Hamill TG; Askew BC; Vyas KP
    Drug Metab Dispos; 1997 Mar; 25(3):355-61. PubMed ID: 9172954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microseparation techniques for the study of the enantioselectivity of drug-plasma protein binding.
    Escuder-Gilabert L; Martínez-Gómez MA; Villanueva-Camañas RM; Sagrado S; Medina-Hernández MJ
    Biomed Chromatogr; 2009 Mar; 23(3):225-38. PubMed ID: 19016227
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.